Pharma Journalist -

Gamida Cell Ltd.  announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment…
Read More...

Xeris Biopharma Holdings, Inc. announced that Tetris Pharma—its commercialization partner for Ogluo in the UK, EEA, and Switzerland—will be acquired by Arecor Therapeutics (AIM: AREC),…
Read More...

Krystal Biotech, Inc. announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate KB407 in a clinical…
Read More...

GreenLight Biosciences and Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved STELARA (ustekinumab) for the treatment of…
Read More...

GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and…
Read More...

Novartis and the University of California, Berkeley have extended their research-based collaboration to develop new technologies for the discovery of next-generation therapeutics,…
Read More...

Melinta Therapeutics, LLC and Cidara Therapeutics announced that they have entered into a License Agreement to facilitate a strategic partnership to commercialize rezafungin, a novel,…
Read More...

Novavax, Inc. announced that Nuvaxovid COVID-19 vaccine received expanded manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for primary…
Read More...

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib 45 mg and 15 mg and 30 mg ) for the treatment of adult patients with moderately to severely active…
Read More...